Clinical Trial Update: Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV [NA]

View source ↗

Summary

Clinical trial update indicating semaglutide is being studied for weight loss in people with HIV; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Obesity

Drugs mentioned

• semaglutide (Wegovy) (semaglutide)

Snippet

Sponsor: University College Dublin | Conditions: Obesity, HIV-1-infection | NA | Status: RECRUITING